Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported earnings of ($2.43) per share missing Walls Streets expectations.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported 9/30/2018 earnings this Morning, coming in at ($2.43) per share, missing Wall Street’s estimates of ($2.03) per Share. Revenue for the quarter came in at $2.07 million missing the streets estimates of $22.66 million



      Recent Trading for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
      Shares of Alnylam Pharmaceuticals, Inc. closed the previous trading session at 76.46 −9.82 11.38% with 81 shares trading hands.

      An ad to help with our costs